(:HCCC)
Business Focus: N/A
Mar 07, 2022 07:32 am ET
Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination
JERUSALEM and WILMINGTON, Del., March 7, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, and Healthcare Capital Corp. (Nasdaq: HCCC) ("HCCC"), a special purpose acquisition company, announced today the successful closing of the previously announced business combination (the "Business Combination"). The combined company will continue to be led by Alpha Tau's existing management team. Alpha Tau's ordinary shares and warrants are expected to begin trading on Tuesday, March 8, 2022, on Nasdaq under the ticker
Jan 20, 2022 05:45 am ET
Alpha Tau Announces New Research Collaboration to Study the Potential of Alpha DaRT to Enhance Immune Stimulation in the Treatment of Breast Cancer
JERUSALEM, Jan. 20, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has signed a sponsored research agreement with investigators at The University of Texas MD Anderson Cancer Center ("MD Anderson") to evaluate potential immune stimulation by combining Alpha DaRT™ with DNA-repair inhibitors and immune checkpoint inhibitors for the treatment of breast tumors.
Jan 03, 2022 06:00 am ET
Alpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer
JERUSALEM, Jan. 3, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has been notified by HekaBio K.K., its clinical trial partner in Japan, that recruitment has been completed in its open-label multi-center pivotal study evaluating the Alpha DaRT in Japanese patients with recurrent Head & Neck cancer after radiotherapy.
Nov 03, 2021 01:00 pm ET
Alpha Tau Announces Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)
JERUSALEM, Nov. 3, 2021 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced today that it has enrolled its first patient in the combination study of Alpha DaRT and pembrolizumab (Keytruda®) at Hadassah Medical Center in Jerusalem, Israel.
Oct 25, 2021 08:25 am ET
Alpha Tau Announces Completion of Enrollment in First US Clinical Trial of Alpha DaRT™ and Achievement of First Primary Objective
JERUSALEM, Oct. 25, 2021 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced today that its US pilot trial for skin cancer has completed enrollment as planned. This announcement comes less than four months after the first patient was recruited into the trial in July 2021. Alpha DaRT sources were successfully implanted into all patients and then removed two to three weeks later as scheduled, and no serious adverse events related to the Alpha DaRT were noted at the time of removal. As such, the trial has met
Jul 13, 2021 01:39 pm ET
Moore Kuehn Encourages CND, HCAQ, HCCC and FPAC Investors to Contact Law Firm
NEW YORK, July 13, 2021 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may seek increased consideration, additional disclosures, or other relief on behalf of the shareholders of these companies:
Jul 08, 2021 07:31 am ET
Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid Tumors Through the Precision Delivery of Alpha Radiation
- Alpha Tau's proprietary Alpha DaRT™ is designed to deliver uniquely potent alpha radiation to destroy solid tumors with localized precision, sparing surrounding healthy tissue, thereby maintaining cancer patients' quality of life. Alpha DaRT™ has recently received FDA's Breakthrough Device Designation for the indication of Squamous Cell Carcinoma of the skin and oral cavity without curative standard of care, and preclinical studies support evaluation across various cancer indications (skin, pancreas, breast and GBM, among others).
Mar 04, 2021 05:30 pm ET
Healthcare Capital Corp. Announces the Separate Trading of its Class A Common Stock and Warrants
Healthcare Capital Corp. (the “Company”) announced today that, commencing March 8, 2021, holders of the 27,500,000 units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A common stock and warrants...
Oct 05, 2020 04:01 pm ET
H/Cell Energy Announces Restructuring Changes
H/Cell Energy Corporation (OTCQB-HCCC) (the “Company”), a company that focuses on the production of hydrogen for clean energy applications, has announced several restructuring changes in order to take advantage of the hydrogen production market...
May 15, 2020 04:11 pm ET
H/Cell Energy Reports FY2020 First Quarter Financial Results
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen and fuel cell technology, has announced financial results for its first quarter ended March 31, 2020. For the three...
Mar 26, 2020 09:10 am ET
H/Cell Energy Obtains Contract to Equip Coronavirus Tents
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions, announced today that, through its PVBJ subsidiary, it has received a contract to equip mobile coronavirus tents with environmental...
Mar 25, 2020 05:15 pm ET
H/Cell Energy Reports FY2019 Year End Financial Results
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen and fuel cell technology, has announced financial results for its fiscal year ended December 31, 2019. Fiscal Year...
Jan 15, 2020 12:02 pm ET
$800k in New Contracts Awarded to H/Cell Energy
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen and fuel cell technology, announced that it has been awarded $800k in new contracts for renewable energy, environmental...
Dec 05, 2019 11:07 am ET
H/Cell Energy Awarded $600k in New Projects
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen and fuel cell technology, announced that it has been awarded $600k in new projects for environmental systems and...
Nov 12, 2019 04:04 pm ET
H/Cell Energy Reports FY2019 Third Quarter Financial Results
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen and fuel cell technology, has announced financial results for its third quarter ended September 30, 2019. For the...
Oct 16, 2019 11:21 am ET
H/Cell Energy Receives $700k in New Contracts
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen and fuel cell technology, announced that it has received $700k in new contracts for environmental systems and general...
Oct 02, 2019 04:04 pm ET
H/Cell Energy Adds $500k in New Projects to Backlog
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen and fuel cell technology, announced that it has been awarded over $500k in new contracts for environmental systems and...
Sep 12, 2019 04:04 pm ET
$1.4 Million in New Contracts Awarded to H/Cell Energy
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen and fuel cell technology, announced that it has been awarded over $1.4 million in new contracts for environmental...
Sep 04, 2019 04:04 pm ET
H/Cell Energy Completes Over $1.2 Million in Projects
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen and fuel cell technology, announced that it has completed over $1.2 million in various environmental systems and...
Aug 07, 2019 09:05 am ET
H/Cell Energy Reports FY2019 Second Quarter Financial Results
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen and fuel cell technology, has announced financial results for its second quarter ended June 30, 2019. For the three...
Jul 15, 2019 08:00 am ET
H/Cell Energy Announces $3 Million Equity Investment Commitment
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen and fuel cell technology, announced that it has entered into an equity purchase agreement with GHS Investments LLC...
May 16, 2019 08:11 am ET
H/Cell Energy Reports FY2019 First Quarter Financial Results
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen and fuel cell technology, has announced financial results for its first quarter ended March 31, 2019. For the three...
Mar 26, 2019 04:05 pm ET
H/Cell Energy Reports FY2018 Year End Financial Results
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen and fuel cell technology, has announced financial results for its fiscal year ended December 31, 2018. Fiscal Year...
Feb 11, 2019 08:11 am ET
H/Cell Energy Commended By Australian Energy Minister
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen and fuel cell technology, announced that through its Australian subsidiary, The Pride Group www.thepridegroup.com.au it...
Dec 03, 2018 01:10 pm ET
H/Cell Energy Awarded Contracts and Panel Selection
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen and fuel cell technology, announced that through its Australian subsidiary, The Pride Group www.thepridegroup.com.au it...
Nov 08, 2018 04:35 pm ET
H/Cell Energy Reports FY2018 Third Quarter Financial Results
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen energy systems, has announced financial results for its fiscal 2018 third quarter ended September 30, 2018. For the...
Aug 10, 2018 05:05 pm ET
H/Cell Energy Reports FY2018 Second Quarter Financial Results
H/Cell Energy Corporation (OTCQB-HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen energy systems, has announced financial results for its fiscal 2018 second quarter ended June 30, 2018. For the three...
Jun 27, 2018 05:00 pm ET
H/Cell Energy Reports FY2018 First Quarter Financial Results
H/Cell Energy Corporation (OTCQB:HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen energy systems, has announced financial results for its fiscal 2018 first quarter ended March 31, 2018. For the three...
Apr 02, 2018 04:11 pm ET
H/Cell Energy Reports FY2017 Year End Financial Results
FLEMINGTON, N.J., April 02, 2018 (GLOBE NEWSWIRE) -- H/Cell Energy Corporation (OTCQB:HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen energy systems, has announced financial results for its fiscal year ended December 31, 2017.
Feb 05, 2018 09:20 am ET
H/Cell Energy Acquires PVBJ
FLEMINGTON, N.J., Feb. 05, 2018 (GLOBE NEWSWIRE) -- H/Cell Energy Corporation (OTCQB:HCCC), a company developing clean energy solutions featuring hydrogen energy systems, has announced that effective February 1, 2018, it acquired PVBJ Inc. (“PVBJ”) of Downingtown, Pennsylvania for...
Nov 09, 2017 04:11 pm ET
H/Cell Energy Reports FY2017 Third Quarter Results
FLEMINGTON, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- H/Cell Energy Corporation (OTCQB:HCCC) (“HCCC”), a company that designs and implements clean energy solutions featuring hydrogen energy systems, has announced financial results for its third fiscal quarter ended September 30, 2017.
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.